[The Depo-Provera treatment of mastopathy patients].
35 women with diffuse fibrous-cystic mastopathy were treated with gestagen slow-releasing drug "Depo-Provera". Use of the drug made part of the patients feel better and promoted regression of objective signs of the disease. Conclusion was made that administration of the drug in mastopathy caused by hormonal disorders is pathogenetically substantiated method of treatment.
A G
AG
Khomasuridze
R A
RA
Manusharova
D000328:Adult; D004958:Estradiol / Q000097:blood; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D008597:Menstrual Cycle / Q000097:blood / Q000187:drug effects; D008599:Menstruation Disturbances / Q000097:blood / Q000188:drug therapy*; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood / Q000187:drug effects; D012074:Remission Induction
D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D017258:Medroxyprogesterone Acetate
Lechenie depo-proverom bol'nykh mastopatieĭ.